Takeda Pharmaceutical Co Ltd 2025 Annual Report with Sustainability Disclosures
Company: Takeda Pharmaceutical Co Ltd
Sector: Manufacturing
Country: Japan
Year: 2025
Type: Annual Report with Sustainability Disclosures
Pages: 162
The report presents Takeda's FY2024 consolidated performance, including reported revenue of 4,581.6 billion yen and strong Growth & Launch Products momentum. It highlights that the company exceeded its prior Scope 1 and 2 reduction target and committed to new SBTi-validated targets. It also reports 1,975 newly enrolled patients in affordability-based assistance programs in FY2024.
Reporting standards, commitments and assurance details are available with a free account.
Data Services
From bulk PDFs to structured indicators and machine-readable documents.